Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $138
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Matt Miksic maintains an Equal-Weight rating on DexCom (NASDAQ:DXCM) and raises the price target from $115 to $138.
July 31, 2023 | 10:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on DexCom and raises the price target from $115 to $138, which could potentially lead to an increase in the stock price.
The raised price target by Barclays indicates a positive outlook for DexCom. This could potentially lead to an increase in the stock price as it suggests that the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100